Literature DB >> 18554945

Histological and molecular temporomandibular joint analyses after mandibular advancement surgery: study in minipigs.

Ricardo de Lima Navarro1, Paula Vanessa Pedron Oltramari, Eduardo Sant'Ana, José Fernando Castanha Henriques, Rumio Taga, Tânia Mary Cestari, Paulo César Rodrigues Conti, Fernando Queiroz Cunha, Carlos Ferreira Santos.   

Abstract

OBJECTIVES: The objective of this study was to elucidate the changes occurring in the temporomandibular joint (TMJ) after surgical mandibular advancement with different fixation techniques: bicortical screws (rigid fixation) and miniplates (semi-rigid fixation). STUDY
DESIGN: Eighteen minipigs were equally and randomly divided into 3 groups: Group I (control), nonoperated animals; Group II, animals submitted to surgical advancement surgery and osteosynthesis by bicortical screws; and Group III, animals submitted to surgical advancement surgery and osteosynthesis by miniplates. Four months after the surgeries, the presence of interleukin (IL)-6 and IL-10 in synovial fluid samples was assessed in ELISA experiments. TMJs were histologically prepared.
RESULTS: Higher levels of IL-10 (P = .0436) were found for Group II. Descriptive histological analysis was compatible with the ELISA findings.
CONCLUSIONS: Rigid fixation evokes more pronounced signs of bone remodeling in the TMJ, whereas malleable fixation promotes a more intense inflammatory activity. Therefore, rigid fixation seems to transmit a higher impact of postoperative masticatory forces to the TMJ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554945     DOI: 10.1016/j.tripleo.2008.01.026

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  1 in total

Review 1.  TMJ response to mandibular advancement surgery: an overview of risk factors.

Authors:  José Valladares-Neto; Lucia Helena Cevidanes; Wesley Cabral Rocha; Guilherme de Araújo Almeida; João Batista de Paiva; José Rino-Neto
Journal:  J Appl Oral Sci       Date:  2014 Jan-Feb       Impact factor: 2.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.